Trump Administration Quietly Approves $7 Billion in Unannounced Weapons Sales to UAE 
Venezuela Appoints New Defense Minister as Rodriguez Reshapes Military Leadership 
Trump Replaces DHS Secretary Kristi Noem With Sen. Markwayne Mullin After Senate Criticism 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
FAA Issues Ground Stop for JetBlue Airways Flights Across All Destinations 
Amazon's AWS Could Hit $600 Billion in Revenue as AI Reshapes Cloud Growth 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Tabletop particle accelerator could transform medicine and materials science 
U.S. Pulls Back Proposed AI Chip Export Rule Amid Policy Uncertainty 
Cyberattack on Stryker Triggers U.S. Government Warning Over Microsoft Intune Security 
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Micron Technology Plans Second Taiwan Chip Facility to Meet AI Memory Demand 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
